Dr. Rizwan Ahmad's lab at Ohio State University focuses on advancing cardiac imaging techniques to improve the diagnosis and treatment of heart valve diseases, particularly mitral valve regurgitation. The team is developing a new MRI protocol that enhances the speed and accuracy of blood flow measurements within the heart, aiming to enable better clinical decisions for patients with heart conditions. This research has the potential to significantly improve patient outcomes by providing more precise assessments compared to current methods.

Dr. Ming-Chen Hsu’s lab at Iowa State University focuses on improving heart valve disease treatments through advanced computer modeling and machine learning. They develop a digital twin technology that simulates how heart valves work to help doctors personalize interventions for patients. The goal is to enhance treatment effectiveness, make healthcare more efficient, and improve patients' quality of life.

Dr. Xiaoguang Margaret Liu's lab at Ohio State University focuses on developing innovative treatment strategies for triple-negative breast cancers (TNBCs), which are known for their aggressive nature and poor response to conventional therapies. By combining immunotherapy with novel drug delivery systems and gene therapies, the lab aims to improve cancer treatment efficacy and reduce recurrence rates. Key areas of research include antibody-drug conjugates and mitochondrial gene therapy, both designed to engage the immune system while directly targeting cancer cells.